D. E. Shaw & Co., Inc. - KYTHERA BIOPHARMACEUTICALS I ownership

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of KYTHERA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q3 2015$24,586,000
+35.5%
327,904
+36.1%
0.04%
+33.3%
Q2 2015$18,140,000
+518.5%
240,866
+311.9%
0.03%
+575.0%
Q1 2015$2,933,000
+352.6%
58,470
+212.9%
0.00%
+300.0%
Q4 2014$648,00018,6850.00%
Other shareholders
KYTHERA BIOPHARMACEUTICALS I shareholders Q3 2023
NameSharesValueWeighting ↓
Palo Alto Investors LP 900,559$33,636,0003.14%
Redmile Group, LLC 557,761$20,777,0002.56%
SENZAR ASSET MANAGEMENT, LLC 79,000$2,951,0002.41%
Aureus Asset Management, LLC 134,465$5,022,0001.36%
REGENTATLANTIC CAPITAL LLC 193,454$7,226,0000.70%
PFM Health Sciences, LP 831,840$31,069,0000.62%
EAM Investors, LLC 55,201$2,056,0000.37%
Dynamic Technology Lab Private Ltd 5,560$207,0000.34%
Polar Capital LLP 350,000$13,038,0000.31%
Old West Investment Management, LLC 10,773$402,0000.24%
View complete list of KYTHERA BIOPHARMACEUTICALS I shareholders